ES2204613T3 - Androgenos 7-alfa alquilo oralmente activos. - Google Patents

Androgenos 7-alfa alquilo oralmente activos.

Info

Publication number
ES2204613T3
ES2204613T3 ES00936686T ES00936686T ES2204613T3 ES 2204613 T3 ES2204613 T3 ES 2204613T3 ES 00936686 T ES00936686 T ES 00936686T ES 00936686 T ES00936686 T ES 00936686T ES 2204613 T3 ES2204613 T3 ES 2204613T3
Authority
ES
Spain
Prior art keywords
alkyl
ethyl
compound
ethenyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00936686T
Other languages
English (en)
Spanish (es)
Inventor
Jaap Louw Van Der
Dirk Leysen
Roberta Buma Bursi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2204613T3 publication Critical patent/ES2204613T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES00936686T 1999-04-06 2000-03-31 Androgenos 7-alfa alquilo oralmente activos. Expired - Lifetime ES2204613T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201070 1999-04-06
EP99201070 1999-04-06

Publications (1)

Publication Number Publication Date
ES2204613T3 true ES2204613T3 (es) 2004-05-01

Family

ID=8240066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00936686T Expired - Lifetime ES2204613T3 (es) 1999-04-06 2000-03-31 Androgenos 7-alfa alquilo oralmente activos.

Country Status (10)

Country Link
US (2) US6756366B1 (https=)
EP (1) EP1212345B1 (https=)
JP (1) JP2002541153A (https=)
AT (1) ATE246703T1 (https=)
AU (1) AU5209600A (https=)
CO (1) CO5160345A1 (https=)
DE (1) DE60004377T2 (https=)
ES (1) ES2204613T3 (https=)
PE (1) PE20010029A1 (https=)
WO (1) WO2000059920A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
WO2003059931A1 (en) * 2002-01-21 2003-07-24 Akzo Nobel N.V. PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
DK2278880T3 (da) * 2008-04-09 2012-11-12 Pherin Pharm Inc Steroidbehandling af hedeture
US20120214987A1 (en) * 2010-12-15 2012-08-23 Yu Ge Methods and compounds for preparing 3alpha-oxygen substituted steroids

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755689A (fr) * 1969-09-03 1971-03-03 Upjohn Co Procede de fabrication de nouvelles 7 beta-alkyl-19- nortestosterones
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6037339A (en) * 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ES2134313T3 (es) * 1993-03-05 1999-10-01 Akzo Nobel Nv Utilizacion de derivados de pregnano para el tratamiento de tumores.
IL113816A (en) * 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical compositions containing desogestrel their preparation and use
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
RU2159618C2 (ru) * 1995-06-22 2000-11-27 Акцо Нобель Н.В. Прессованные таблетки дезогестрела, изготовленные способом сухого гранулирования
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
ZA968873B (en) * 1995-11-06 1997-05-28 Akzo Nobel Nv Isomerisation of equillin
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
CA2200423C (en) * 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
US6177420B1 (en) * 1997-05-16 2001-01-23 Akzo Nobel N.V. 20-aralkyl-5α-pregnane derivatives
US6262282B1 (en) * 1997-06-04 2001-07-17 Akzo Nobel N.V. 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
EP0927556B1 (en) * 1997-09-23 2000-08-30 Akzo Nobel N.V. Dosage units of steroids with a seal coating for the steroids
US6080773A (en) * 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
NZ504351A (en) * 1997-11-14 2002-10-25 Akzo Nobel Nv Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
DK1042353T3 (da) * 1997-12-18 2002-11-04 Akzo Nobel Nv 17-beta-aryl(arylmethyl)oxy(thio)alkylandrostanderivater
NZ506465A (en) * 1998-02-26 2003-08-29 Akzo Nobel Nv Derivatives of azetidine and pyrrolidine
NZ508299A (en) * 1998-06-19 2003-04-29 Akzo Nobel Nv Testosterone derivative
AU759344B2 (en) * 1998-12-11 2003-04-10 Akzo Nobel N.V. 22S-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
US6498153B1 (en) * 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
ATE229538T1 (de) * 1999-03-09 2002-12-15 Akzo Nobel Nv 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
US6677329B1 (en) * 1999-09-06 2004-01-13 Akzo Nobel N V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
AU778017B2 (en) * 1999-12-02 2004-11-11 N.V. Organon 14,15-beta-methylene substituted androgens
DE60130748T2 (de) * 2000-03-27 2008-07-17 N.V. Organon Nicht-steroidale tetracyclische verbindungen für östrogen-verwandte behandlungen
KR20030027052A (ko) * 2000-08-23 2003-04-03 악조 노벨 엔.브이. 의료용 10-아릴-11Ｈ-벤조[ｂ]플루오렌 유도체 및 유사체

Also Published As

Publication number Publication date
PE20010029A1 (es) 2001-01-26
CO5160345A1 (es) 2002-05-30
WO2000059920A3 (en) 2001-02-15
EP1212345B1 (en) 2003-08-06
US20040209853A1 (en) 2004-10-21
WO2000059920A2 (en) 2000-10-12
JP2002541153A (ja) 2002-12-03
AU5209600A (en) 2000-10-23
DE60004377D1 (de) 2003-09-11
DE60004377T2 (de) 2004-06-09
ATE246703T1 (de) 2003-08-15
EP1212345A2 (en) 2002-06-12
US6756366B1 (en) 2004-06-29

Similar Documents

Publication Publication Date Title
ES2213596T3 (es) Androgenos con una actividad oral.
US7196074B2 (en) Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
ES2258037T3 (es) Androgenos sustituidos con 14,15-beta-metilen.
ES2204613T3 (es) Androgenos 7-alfa alquilo oralmente activos.
JP2010529153A (ja) １７β−シアノ−１９−ノル−アンドロスタ−４−エン誘導体、その使用、及び当該誘導体を含む医薬
SK3282002A3 (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
US6881728B1 (en) 14-β, 17-α-hydroxymethylandrostane derivatives as androgens
HUT73238A (en) 15,15-dialkyl-substituted derivatives of estradiol and pharmaceutical compositions containing the same
EP1846434B1 (en) NANDROLONE 17ß-CARBONATES
JP4279552B2 (ja) 新規アンドロゲンとしてのメチレンステロイド
AU2002258664B2 (en) Methods of making, using and pharmaceutical formulations comprising 7alpha, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17-esters thereof
CN1481388A (zh) 具有雄激素-孕激素混合活性的14(15)-不饱和的15-和/或16-取代的雄激素类